JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120453

CGS 21680, A2A agonist

Be the first to review this product! Submit a review

|

(7 Publications)

MW 536 Da, Purity >96%. Achieve your results faster with highly validated, pure and trusted compounds.
1 Images
Chemical Structure - CGS 21680, A2A agonist (AB120453)
  • Chemical Structure

Lab

Chemical Structure - CGS 21680, A2A agonist (AB120453)

2D chemical structure image of ab120453, CGS 21680, A2A agonist

Key facts

CAS number

124431-80-7

Purity

>96%

Form

Solid

form

Molecular weight

536 Da

Molecular formula

C<sub>2</sub><sub>3</sub>H<sub>3</sub><sub>0</sub>ClN<sub>7</sub>O<sub>6</sub>

PubChem

10256643

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biochemical name

CGS 21680 hydrochloride

Canonical smiles

CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)O)N)O)O.Cl

Isomeric smiles

CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)O)N)O)O.Cl

InChi

InChI=1S/C23H29N7O6.ClH/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32;/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29);1H/t16-,17+,18-,22+;/m0./s1

IUPAC Name

3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid;hydrochloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

British journal of pharmacology 181:3779-3795 PubMed38877785

2024

An agonist of the adenosine A receptor, CGS21680, promotes corneal epithelial wound healing via the YAP signalling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Qiuqin Sun,Nan Jiang,Rui Yao,Yue Song,Zewen Li,Wei Wang,Jiangfan Chen,Wei Guo

Frontiers in pharmacology 13:840134 PubMed35387355

2022

Adenosine A2A Receptor: A New Neuroprotective Target in Light-Induced Retinal Degeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Manuel Soliño,Ignacio M Larrayoz,Ester María López,Manuel Rey-Funes,Mariana Bareiro,Cesar Fabián Loidl,Elena Girardi,Alfredo Martínez,Juan José López-Costa

The Tohoku journal of experimental medicine 249:275-283 PubMed31875581

2019

Adenosine Attenuates Aortic Smooth Muscle Cell Calcification through A Adenosine Receptor.

Applications

Unspecified application

Species

Unspecified reactive species

Kenta Fujimoto,Atsushi Shioi,Yuya Miki,Yoshinori Kakutani,Tomoaki Morioka,Tetsuo Shoji,Masanori Emoto,Masaaki Inaba

Journal of leukocyte biology 105:1225-1234 PubMed30907983

2019

Adenosine from a biologic source regulates neutrophil extracellular traps (NETs).

Applications

Unspecified application

Species

Unspecified reactive species

Kai Xu,Kimberly A Cooney,Eric Y Shin,Lanfang Wang,Juline N Deppen,Sydney C Ginn,Rebecca D Levit

Theranostics 8:5713-5730 PubMed30555576

2018

Caffeine Protects Skin from Oxidative Stress-Induced Senescence through the Activation of Autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Yi-Fang Li,Shu-Hua Ouyang,Long-Fang Tu,Xi Wang,Wei-Lin Yuan,Guo-En Wang,Yan-Ping Wu,Wen-Jun Duan,Hong-Min Yu,Zhong-Ze Fang,Hiroshi Kurihara,Youwei Zhang,Rong-Rong He

Cardiovascular diabetology 16:142 PubMed29096622

2017

Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Masashi Kawamura,Michael J Paulsen,Andrew B Goldstone,Yasuhiro Shudo,Hanjay Wang,Amanda N Steele,Lyndsay M Stapleton,Bryan B Edwards,Anahita Eskandari,Vi N Truong,Kevin J Jaatinen,Arnar B Ingason,Shigeru Miyagawa,Yoshiki Sawa,Y Joseph Woo

Immunity, inflammation and disease 6:72-80 PubMed29027376

2017

Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Liu,Marwan Alahiri,Bianca Ulloa,Boxun Xie,Saud A Sadiq
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com